Radebeul, Germany

Dieter Lohmann

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Arzneimittelwerk Dresden Gmbh, Arzneimittelerk Dresden G.m.b.h., Resprotect Gmbh. Active years: 1992-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Lohmann. Retrieved from https://idiyas.com/inventor/dieter-lohmann-56rg9u29

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 88.9



Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1992-2013

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Journey of Dieter Lohmann

Introduction:

Dieter Lohmann, a prominent inventor hailing from Radebeul, Germany, stands as a beacon of inspiration in the realm of technological advancement. With a total of 9 patents under his belt, Lohmann's unwavering passion for innovation continues to shape the future of inventors worldwide.

Latest Patents:

1. "Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy": Lohmann's groundbreaking invention revolves around specialized nucleosides designed to combat resistance in cytostatic therapy for cancer patients.

2. "N-acyl-4-phenyl-pyrrolidin-2-ones and method for preparing": This patent showcases Lohmann's contribution to cerebral functional disorder treatment through the synthesis of N-acyl-4-phenyl-pyrrolidin-2-ones.

Career Highlights:

Throughout his illustrious career, Lohmann has made significant strides in the field of pharmaceuticals. Notable highlights include his tenure at Arzneimittelwerk Dresden GmbH and Resprotect GmbH, where he spearheaded innovative projects that paved the way for groundbreaking medical advancements.

Collaborations:

Lohmann's collaborative spirit has been integral to his success, with esteemed coworkers such as Reni Bartsch and Hildegard Poppe playing crucial roles in realizing his inventive visions. Their joint efforts have undoubtedly contributed to Lohmann's prolific patent portfolio.

Conclusion:

In conclusion, Dieter Lohmann's transformative contributions to the field of pharmaceutical innovation underscore his status as a trailblazing inventor. His relentless pursuit of excellence and commitment to pushing the boundaries of technological evolution serve as a testament to his enduring legacy in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…